Intravenous Recombinant Human Plasma Gelsolin Safety and Pharmacokinetics Evaluated in Phase 1 Trial of Healthy Volunteers
Can this new IV drug be safely given? Early results show mild effects.
This Phase 1 randomized controlled trial evaluated the safety and pharmacokinetics of intravenous recombinant human plasma gelsolin in 32 he…
A new IV drug caused only mild side effects in healthy volunteers, but doctors must wait for more data before using it to treat sick patient…
Phase 1 cohort study assesses prophylactic pDNA vaccine safety and immunogenicity in healthy adults.
Early study of a COVID-19 DNA vaccine in healthy adults showed no serious safety issues.
This Phase 1 cohort study enrolled 42 eligible healthy subjects to evaluate a prophylactic COVID-19 pDNA vaccine compared to placebo (Saline…
A new COVID-19 DNA vaccine showed no serious safety issues in healthy adults after six months of monitoring.